Cargando…

Response to Letter to the Editor From Green and Gosmanov: “Tall Cell Percentage Alone in PTC Without Aggressive Features Should not Guide Patients’ Clinical Management”

Detalles Bibliográficos
Autores principales: Viola, David, Poma, Anello Marcello, Elisei, Rossella, Basolo, Fulvio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113788/
https://www.ncbi.nlm.nih.gov/pubmed/35100613
http://dx.doi.org/10.1210/clinem/dgac055
_version_ 1784709645537902592
author Viola, David
Poma, Anello Marcello
Elisei, Rossella
Basolo, Fulvio
author_facet Viola, David
Poma, Anello Marcello
Elisei, Rossella
Basolo, Fulvio
author_sort Viola, David
collection PubMed
description
format Online
Article
Text
id pubmed-9113788
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-91137882022-05-18 Response to Letter to the Editor From Green and Gosmanov: “Tall Cell Percentage Alone in PTC Without Aggressive Features Should not Guide Patients’ Clinical Management” Viola, David Poma, Anello Marcello Elisei, Rossella Basolo, Fulvio J Clin Endocrinol Metab Online Only Articles Oxford University Press 2022-02-01 /pmc/articles/PMC9113788/ /pubmed/35100613 http://dx.doi.org/10.1210/clinem/dgac055 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Online Only Articles
Viola, David
Poma, Anello Marcello
Elisei, Rossella
Basolo, Fulvio
Response to Letter to the Editor From Green and Gosmanov: “Tall Cell Percentage Alone in PTC Without Aggressive Features Should not Guide Patients’ Clinical Management”
title Response to Letter to the Editor From Green and Gosmanov: “Tall Cell Percentage Alone in PTC Without Aggressive Features Should not Guide Patients’ Clinical Management”
title_full Response to Letter to the Editor From Green and Gosmanov: “Tall Cell Percentage Alone in PTC Without Aggressive Features Should not Guide Patients’ Clinical Management”
title_fullStr Response to Letter to the Editor From Green and Gosmanov: “Tall Cell Percentage Alone in PTC Without Aggressive Features Should not Guide Patients’ Clinical Management”
title_full_unstemmed Response to Letter to the Editor From Green and Gosmanov: “Tall Cell Percentage Alone in PTC Without Aggressive Features Should not Guide Patients’ Clinical Management”
title_short Response to Letter to the Editor From Green and Gosmanov: “Tall Cell Percentage Alone in PTC Without Aggressive Features Should not Guide Patients’ Clinical Management”
title_sort response to letter to the editor from green and gosmanov: “tall cell percentage alone in ptc without aggressive features should not guide patients’ clinical management”
topic Online Only Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113788/
https://www.ncbi.nlm.nih.gov/pubmed/35100613
http://dx.doi.org/10.1210/clinem/dgac055
work_keys_str_mv AT violadavid responsetolettertotheeditorfromgreenandgosmanovtallcellpercentagealoneinptcwithoutaggressivefeaturesshouldnotguidepatientsclinicalmanagement
AT pomaanellomarcello responsetolettertotheeditorfromgreenandgosmanovtallcellpercentagealoneinptcwithoutaggressivefeaturesshouldnotguidepatientsclinicalmanagement
AT eliseirossella responsetolettertotheeditorfromgreenandgosmanovtallcellpercentagealoneinptcwithoutaggressivefeaturesshouldnotguidepatientsclinicalmanagement
AT basolofulvio responsetolettertotheeditorfromgreenandgosmanovtallcellpercentagealoneinptcwithoutaggressivefeaturesshouldnotguidepatientsclinicalmanagement